SEC Form 4 · accession 0001213900-19-003528
Hoth Therapeutics, Inc. · RKTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew D. Eitner
10% Owner
Period of report
Feb 20, 2019
Accepted (ET)
Mar 4, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2019 | C | 15,000 | — | A | 765,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1 | — | Feb 20, 2019 | C | 15,000 | D | — | — | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock at a 1-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Articles of Incorporation, as amended).